Advertisement

Supply Chain



Mayo Clinic's Supplier Diversity Initiative program, launched in 2015, aims to boost the amount of supply contracts given to companies owned by minorities, women and veterans.

An immunotherapy drug tested on non-small cell lung cancer patients proved so effective in a recent clinical trial that the study has been cut short and the drug is being fast-tracked for approval from the Food and Drug Administration.

Advertisement

Most Read

Advertisement
Advertisement